23andMe was founded in 2006 and sells DNA tests for various genetic diseases.

Since its inception, the company has picked up more than 230 million u.s. dollars, equivalent to about 1.8 billion kronor, from among others, Google, Genentech and Johnson & Johnson.

According to Techcrunch keeps the company now to take in about 1.6 billion.

the funds will make it possible for the company to continue to invest in its genetikforskning and develop new products without having to go to the stock exchange, which Techcrunch sources say that ceo Anne Wojcicki wants to avoid for the moment.

23andMe declined to comment to Techcrunch data.

In recent years, 23andMe has focused more on the research after the us FDA, 2013 ordered them to stop selling their DNA tests.

The text above is a summary, you can read full article here.